BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Civitas Therapeutics 

190 Everett Ave.

Chelsea  Massachusetts  02150  U.S.A.
Phone: 617-968-3004 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
Civitas Therapeutics To Present At The 21st Annual Future Leaders In The Biotech Industry Conference 3/24/2014 9:30:47 AM    More...
Civitas Therapeutics To Present At Cowen and Company 34th Annual Health Care Conference 2/25/2014 7:31:27 AM    More...
Civitas Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/6/2014 7:24:42 AM    More...
Civitas Therapeutics Appoints Mark Iwicki President And Chief Executive Officer 1/29/2014 7:21:59 AM    More...
Civitas Therapeutics Appoints Timothy S. Nelson As Chairman Of The Board Of Directors 1/8/2014 8:49:24 AM    More...
Civitas Therapeutics To Present At Piper Jaffray And Oppenheimer Investor Conferences In December 11/26/2013 7:06:19 AM    More...
Civitas Therapeutics Extends CVT-301 Patent Protection Into 2032 11/8/2013 9:48:44 AM    More...
Civitas Therapeutics Raises $38 Million 9/11/2013 6:58:22 AM    More...
Civitas Therapeutics Initiates Phase 2b Clinical Study of CVT-301, Inhaled L-dopa for Parkinson’s Disease 9/5/2013 10:23:18 AM    More...
Civitas Therapeutics to Present at Wedbush Securities and Canaccord Genuity Investor Conferences in August 8/7/2013 9:00:36 AM    More...
123

//-->